Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections - Schneeweiss, S; Korzenik, J; Solomon, D H; Canning, C; Lee, J; Bressler, B (Aliment Pharmacol Ther, 2009)